United States - English - NLM (National Library of Medicine)

sagent pharmaceuticals - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin 20000 [usp'u] in 1 ml - heparin sodium injection is indicated for: - prophylaxis and treatment of venous thrombosis and pulmonary embolism; - prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; - atrial fibrillation with embolization; - treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); - prevention of clotting in arterial and cardiac surgery; - prophylaxis and treatment of peripheral arterial embolism. - anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures. the use of heparin sodium is contraindicated in patients with the following conditions: - history of heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis [see warnings and precautions (5.3)] ; - known hypersensitivity to heparin or pork products (e.g., anaphylactoid reactions) [see adverse reactions (6.1)]; -

United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc - heparin sodium (unii: zz45ab24ca) (heparin - unii:t2410km04a) - heparin 5000 [usp'u] in 1 ml - heparin sodium injection is indicated for: anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; low-dose regimen for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease (see dosage and administration ); prophylaxis and treatment of pulmonary embolism; atrial fibrillation with embolization; diagnosis and treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac surgery; prophylaxis and treatment of peripheral arterial embolism. heparin may also be employed as an anticoagulant in blood transfusions, extracorporeal circulation, and dialysis procedures and in blood samples for laboratory purposes. heparin sodium should not be used in patients with the following conditions: severe thrombocytopenia; when suitable blood coagulation test

Canada - English - Health Canada

fresenius kabi canada ltd - heparin sodium - solution - 10000unit - heparin sodium 10000unit - heparins

Kenya - English - Pharmacy and Poisons Board

heparin sodium injection usp 25000iu/5ml - injection - heparin sodium usp 25000iu - heparin

Israel - English - Ministry of Health

teva medical ltd - heparin sodium - solution for infusion - heparin sodium 2 u/ml - heparin - heparin - anticoagulant in extracorporeal circulation, dialysis procedures, an aid in the maintenance of catheter patency.

Canada - English - Health Canada

pfizer canada ulc - heparin sodium - solution - 2unit - heparin sodium 2unit - heparins

Canada - English - Health Canada

hospira healthcare ulc - heparin sodium - solution - 50unit - heparin sodium 50unit - heparins

Canada - English - Health Canada

hospira healthcare ulc - heparin sodium - solution - 40unit - heparin sodium 40unit - heparins

Canada - English - Health Canada

b. braun medical inc - heparin sodium; sodium chloride; sodium phosphate dibasic; citric acid - solution - 200unit; 900mg; 430mg; 37mg - heparin sodium 200unit; sodium chloride 900mg; sodium phosphate dibasic 430mg; citric acid 37mg - heparins

Canada - English - Health Canada

pfizer canada ulc - heparin sodium - solution - 1000unit - heparin sodium 1000unit - heparins